2018
DOI: 10.1080/0284186x.2018.1473640
|View full text |Cite
|
Sign up to set email alerts
|

Do we know what to do with our nonagenarian and centenarian patients with metastatic colorectal cancer (mCRC)? Results from the South Australian mCRC registry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 29 publications
0
4
0
Order By: Relevance
“…Centenarians, however, have traditionally been excluded from intervention trials. The evidence-based practice for caring of this population has just begun to be established, showing different treatment responses and adverse event profiles (Sobani et al, 2018;Tapia Rico et al, 2018). Findings from this study support the heterogeneity in ADL independence and a multipronged approach to address ADL independence is critical.…”
Section: Relevance For Clinical Practicementioning
confidence: 54%
“…Centenarians, however, have traditionally been excluded from intervention trials. The evidence-based practice for caring of this population has just begun to be established, showing different treatment responses and adverse event profiles (Sobani et al, 2018;Tapia Rico et al, 2018). Findings from this study support the heterogeneity in ADL independence and a multipronged approach to address ADL independence is critical.…”
Section: Relevance For Clinical Practicementioning
confidence: 54%
“…The management of older adults with cancer during the COVID-19 pandemic remains guided by the general principles of geriatric oncology; however, more rigorous and systematic application of screening and assessment tools is strongly recommended. Multiple guidelines recommend that all older adults being considered for cancer treatment should undergo some form of geriatric assessment [12][13][14] to help estimate life expectancy, document vulnerabilities not noted on routine questioning, and guide supportive care strategies. Evidence supports that, at a minimum, function, comorbidity, falls, depression, cognition, and nutrition should be assessed.…”
Section: Older Patientsmentioning
confidence: 99%
“…Progress has been seen also in elderly patients with CRC [17], but especially in octogenarian it is in mCRC limited to a few months in median OS, or from about 2-3 months to 3-6 months [18,19]. In this issue of Acta Oncologica, three articles bring further insight into the management of elderly patients with mCRC [20][21][22].…”
Section: Editorialmentioning
confidence: 99%
“…An Australian group [20] reports the outcome of the oldest mCRC patients, i.e., those over 90 years. One hundred and thirty (3%) patients out of 4199 patients belonged to this group of nonagenarian and centenarian patients.…”
Section: Editorialmentioning
confidence: 99%